Budas, Haniyya .

HRN: 26-27-63  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2024
OXACILLIN 500MG (VIAL)
11/22/2024
11/29/2024
IV
200mg
Q6
Scabies Infection
Waiting Final Action 
11/22/2024
MUPIROCIN 2%, 15G (TUBE)
11/22/2024
11/29/2024
TOPICAL
15g
TID
Scabies With Superimposed Bacterial Infection
Waiting Final Action 
09/22/2025
CEFUROXIME 750MG (VIAL)
09/22/2025
09/29/2025
IV
300mg
Q8H
PCAP C
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: